2022 Hybrid Research Symposium Posters

The 2022 NETRF Hybrid Research Symposium poster session was held at the Boston meeting for presenters that attended in-person, however, all posters were viewable online through the virtual Symposium platform. 

Please note that some presenters chose not to post their presentations online following the meeting and have been respectfully omitted here.

Select Session

Evaluation of DOTATATE-PET After Two Cycles of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs)

Presenter: Duan

Evaluation of Cases with Neuroendocrine Cell Hyperplasia for Classification as Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and Subsequent Whole Exome Sequencing Analysis

Presenter: Merrick

Effect of Epigenetic Treatment on SST2 Expression in Neuroendocrine Tumor Patients

Presenter: Refardt

An in vitro/in vivo platform to test the anti-tumor activity of tyrosine kinase inhibitors in medullary thyroid cancer

Presenter: Vitale

A novel anti-SSTR bispecific T-cell engager (BiTE®)-like molecule for the treatment of neuroendocrine tumors

Presenter: Pelle

A Human Pluripotent Stem Cell-based Model for Lung Carcinoid

Presenter: Chen

3p C NETA TATE: A versatile somatostatin analogue for Al 18 F labeled and therapeutic SSTR2 targeting radiopharmaceuticals

Presenter: Cleeren